INIS
reviews
100%
evaluation
100%
humans
100%
growth
100%
economics
100%
children
100%
growth hormone
100%
height
63%
kidneys
31%
cost
26%
genes
15%
adults
15%
data
10%
comparative evaluations
10%
values
10%
patients
10%
doses
10%
control
5%
inclusions
5%
probability
5%
gain
5%
appraisal
5%
infants
5%
body composition
5%
Nursing and Health Professions
Economic Evaluation
100%
Systematic Review
100%
Growth Disorder
100%
Human Growth Hormone
100%
Prader Willi Syndrome
58%
Growth Hormone Deficiency
58%
Chronic Kidney Failure
50%
Turner Syndrome
50%
Small for Date Infant
50%
Quality Adjusted Life Year
16%
Cost Effectiveness Analysis
16%
Clinical Effectiveness
16%
Body Height
16%
Short Stature
16%
Toddlers
8%
Body Composition
8%
Drug Megadose
8%
Medicine and Dentistry
Growth Disorder
100%
Human Growth Hormone
100%
Systematic Review
100%
Growth Hormone Deficiency
58%
Prader-Willi Syndrome
58%
Chronic Kidney Disease
50%
Small for Gestational Age
50%
Turner Syndrome
50%
Health Care Cost
25%
Homeobox
25%
Short Stature
16%
Quality Adjusted Life Year
16%
Randomized Controlled Trial
16%
Cost-Effectiveness Analysis
16%
Drug Megadose
8%
Catch up Growth
8%
Effectiveness Study
8%
Toddlers
8%
Pharmacology, Toxicology and Pharmaceutical Science
Growth Disorder
100%
Human Growth Hormone
100%
Growth Hormone Deficiency
58%
Prader Willi Syndrome
58%
Chronic Kidney Failure
50%
Small for Date Infant
50%
Turner Syndrome
50%
Randomized Controlled Trial
16%
Short Stature
16%
Effectiveness Study
8%
Psychology
Systematic Review
100%
Human Growth Hormone
100%
Growth Disorder
100%
Prader-Willi Syndrome
58%
Gestational Age
50%
Turner Syndrome
50%
Short Stature
16%
Narrative Review
8%
Analytical Model
8%
Toddlers
8%
Body Composition
8%